Cargando…
Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease
Ulcerative colitis (UC) is a relapsing non-transmural chronic inflammatory disease of the colon characterized by bloody diarrhea. The etiology of UC is unknown. The goal is to reduce the inflammation and induce disease remission in UC patients with active disease. The aim of this study is to investi...
Autor principal: | Mirsepasi-Lauridsen, Hengameh Chloè |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784819/ https://www.ncbi.nlm.nih.gov/pubmed/36556089 http://dx.doi.org/10.3390/jcm11247472 |
Ejemplares similares
-
Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2018) -
Effect of α-Hemolysin Producing E. coli in Two Different Mouse Strains in a DSS Model of Inflammatory Bowel Disease
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2020) -
Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
por: Pisani, Anthea, et al.
Publicado: (2022) -
Dysbiosis Disrupts Gut Immune Homeostasis and Promotes Gastric Diseases
por: Toor, Devinder, et al.
Publicado: (2019) -
Gut microbial dysbiosis in patients with Cushing’s disease in long-term remission. Relationship with cardiometabolic risk
por: Valassi, Elena, et al.
Publicado: (2023)